PPA
ENTL

Parametric Portfolio Associates’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Parametric Portfolio Associates’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-60,769
Closed -$1.48M – 3998
2017
Q4 		$1.48M Buy
60,769
+16,333
+37% +$314K ﹤0.01% 2799
2017
Q3 		$820K Buy
44,436
+10,161
+30% +$176K ﹤0.01% 3151
2017
Q2 		$568K Buy
34,275
+23,387
+215% +$325K ﹤0.01% 3291
2017
Q1 		$150K Buy
10,888
+573
+6% +$9.2K ﹤0.01% 3657
2016
Q4 		$196K Buy
10,315
+101
+1% +$1.94K ﹤0.01% 3600
2016
Q3 		$227K Buy
+10,214
New +$192K ﹤0.01% 3537
2015
Q3 		– Sell
-15,302
Closed -$396K – 3432
2015
Q2 		$396K Buy
+15,302
New +$387K ﹤0.01% 3415

Parametric Portfolio Associates's ENTL Position: Q1 2018 in Review

Parametric Portfolio Associates sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 60,769 shares — an estimated $1.48M sold.

Parametric Portfolio Associates first reported a position in ENTL in Q2 2015 and held it in 7 quarters. The position peaked at $1.48M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Parametric Portfolio Associates reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Parametric Portfolio Associates sold 60,769 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.48M.
  • Parametric Portfolio Associates first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
  • Parametric Portfolio Associates's Entellus Medical, Inc. Common Stock position peaked at $1.48M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Parametric Portfolio Associates's 13F filing for Q1 2018, filed 14 May 2018.